Julia Lostes - Publications

Subcutaneous immunotherapy as a catalyst for decentralized, oncologist-led cancer care: a mixed-methods analysis.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 03, 2026

Integrating C-reactive protein flare and early MRI dynamics for enhanced prediction of immunotherapy response.

Journal: Journal for immunotherapy of cancer

Published: November 30, 2025

First-in-Human, Phase I/II Dose Escalation and Expansion Study of Zelenectide Pevedotin in Patients With Advanced Solid Tumors: Results From Monotherapy Dose Escalation.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 06, 2025

Frequent genetic alterations in myositis autoantigen genes in cancer-associated dermatomyositis.

Journal: Annals of the rheumatic diseases

Published: July 13, 2025

Preclinical data and design of a phase I clinical trial of neoantigen-reactive TILs for advanced epithelial or ICB-resistant solid cancers.

Journal: Immuno-oncology technology

Published: February 06, 2025

Safety of adoptive therapy with tumor-infiltrating lymphocytes and high-dose recombinant interleukin 2 in advanced cutaneous melanoma: a systematic review and meta-analysis.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: December 23, 2024

Clinical protocol phase II study of tumor infiltrating lymphocytes in advanced tumors with alterations in the SWI/SNF complex: the TILTS study.

Journal: Future oncology (London, England)

Published: August 12, 2024

Efficacy and safety of cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma: A multicentre real-world retrospective study from Spain and systematic review of the published data.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: September 30, 2023

Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 19, 2022

Management of Cancer-Associated Myositis.

Journal: Current treatment options in rheumatology

Published: August 24, 2022